Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors

被引:15
作者
Herrero, JI
Quiroga, J
Sangro, B
Beloqui, O
Pardo, F
Cienfuegos, JA
Prieto, J
机构
[1] Univ Navarra, Liver Unit, Clin Univ, Pamplona 31008, Spain
[2] Univ Navarra, Dept Surg, Clin Univ, E-31080 Pamplona, Spain
关键词
D O I
10.1053/jlts.2000.7571
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplant recipients have an increased risk for cardiovascular disease because of a high incidence of obesity, arterial hypertension, diabetes mellitus, and hyperlipidemia. Hyperhomocysteinemia has been found to be an important risk factor for cardiovascular disease in large studies. Pasting serum levels of homocysteine were measured in 105 liver transplant recipients, and hyperhomocysteinemia was defined as a fasting serum homocysteine level greater than 13 mu mol/L. Patients with versus without hyperhomocysteinemia were compared. The possible association of hyperhomocysteinemia with age, sex, cause of liver disease, time elapsed since liver transplantation, immunosuppressive therapy, folic acid level, liver function test results, renal function, and other cardiovascular risk factors was investigated. Patients with serum homocysteine levels greater than 15 mu mol/L were treated with folic acid, 10 mg/d, and serum homocysteine levels were measured again 1 to 3 months later in 10 patients. Hyperhomocysteinemia was detected in 28 patients (27%), In univariate analysis, it was associated with hepatitis C virus infection, treatment with mycophenolate mofetil, and greater serum levels of alkaline phosphatase, gamma-glutamyl transpeptidase, urea, and creatinine, In multivariate analysis, only greater serum levels of creatinine (P = .006) were associated with hyperhomocysteinemia. Treatment with folic acid resulted in a decrease in fasting serum homocysteine levels in 9 of the 10 patients tested (P = .01). Hyperhomocystinemia associated with renal dysfunction, is a frequent finding in liver transplant recipients. Treatment with folic acid may reduce fasting homocysteine levels.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 13 条
[1]   An analysis of late deaths after liver transplantation [J].
Asfar, S ;
Metrakos, P ;
Fryer, J ;
Verran, D ;
Ghent, C ;
Grant, D ;
Bloch, M ;
Burns, P ;
Wall, W .
TRANSPLANTATION, 1996, 61 (09) :1377-1381
[2]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[5]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[6]   The effect of folic acid fortification on plasma folate and total homocysteine concentrations [J].
Jacques, PF ;
Selhub, J ;
Bostom, AG ;
Wilson, PWF ;
Rosenberg, IH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1449-1454
[7]  
MCCULLY KS, 1969, AM J PATHOL, V56, P111
[8]  
Munoz S J, 1995, Liver Transpl Surg, V1, P29
[9]   Homocysteine and cardiovascular disease [J].
Refsum, H ;
Ueland, PM ;
Nygård, O ;
Vollset, SE .
ANNUAL REVIEW OF MEDICINE, 1998, 49 :31-62
[10]   Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women [J].
Rimm, EB ;
Willett, WC ;
Hu, FB ;
Sampson, L ;
Colditz, GA ;
Manson, JE ;
Hennekens, C ;
Stampfer, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05) :359-364